Master Components Secures International Order for Supply of Thermoset Injection Molds
Master Components Limited, formerly known as Master Components Pvt Limited, has secured a significant purchase order from an international entity for the supply of thermoset injection molds. The contract details indicate a substantial deal for the company's specialized manufacturing capabilities.The newly received order specifies the terms and conditions for the supply. The transaction involves an international customer, confirming the company’s reach in the global market. The total value of the purchase order is approximately EURO 25,000, excluding tax.
The deal structure includes defined payment milestones to be completed upon execution. Master Components Limited has confirmed that this contract does not constitute a related party transaction.
Details regarding the order and its associated terms are presented below:
| Particulars | Details |
|---|---|
| Name of Client | International Company |
| Nature of Order | Supply of thermoset injection molds |
| Order Value | Approximately EURO 25,000 excluding tax |
| Execution Deadline | September 11, 2026 |
| Transaction Status | Not a related party transaction |
The terms for the contract stipulate specific payment schedules. The customer has agreed to a 50% advance payment. A further 30% is set to be paid against T1 Trial samples, with the remaining 20% due with taxes upon receipt of the final invoice.
NOVARTIND Stock Price Movement
Novartis India Limited shares today edged higher to close at ₹1329.7, gaining 1.13% and registering a rise of ₹14.90 from the previous close. The stock saw movement within its day's range between ₹1310 and ₹1347.5, with a total volume of 11,516 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.